A Multicenter Prospective Study of Quality of Life in Adult Scoliosis

NCT00854828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 286

Last updated 2021-09-14

Study results available
· View outcomes & findings →

Summary

This is a multicenter study evaluating the effectiveness of nonoperative and operative treatments. The investigators wish to identify important clinical and radiographic determinants of outcomes in the management of adults with symptomatic lumbar scoliosis (ASLS).

Note: Enrollment was complete July 2014. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) funding ended 2/28/17. We continue to follow enrolled subjects while we seek additional funding to follow all subjects through 8 years.

Conditions

  • Scoliosis

Interventions

PROCEDURE

Surgical intervention

Surgical intervention as appropriate for adults with symptomatic lumbar scoliosis

OTHER

Non-operative intervention

Non operative intervention as appropriate for treatment of adults with symptomatic lumbar scoliosis such as: injections, medications, physical therapy, etc.

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH
  • Northwestern University

    collaborator OTHER
  • New York University

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • University of Louisville

    collaborator OTHER
  • Maryland Spine Center

    collaborator OTHER
  • Hospital for Special Surgery, New York

    collaborator OTHER
  • University Health Network, Toronto

    collaborator OTHER
  • Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

    collaborator OTHER
  • Dartmouth College

    collaborator OTHER
  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Keith H Bridwell, MD · Washington University School of Medicine

  • Jon Lurie, MD · Dartmouth-Hitchcock Medical Center

  • Christopher Shaffrey, MD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00854828 on ClinicalTrials.gov